HomeQNCX • NASDAQ
add
Quince Therapeutics Inc
Previous close
$1.50
Day range
$1.43 - $1.55
Year range
$0.51 - $2.45
Market cap
69.90M USD
Avg Volume
299.28K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 12.93M | 49.13% |
Net income | -15.03M | -34.81% |
Net profit margin | — | — |
Earnings per share | -0.34 | — |
EBITDA | -12.90M | -49.45% |
Effective tax rate | -0.31% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 31.60M | -53.41% |
Total assets | 107.09M | -32.77% |
Total liabilities | 88.51M | 3.99% |
Total equity | 18.58M | — |
Shares outstanding | 45.47M | — |
Price to book | 3.57 | — |
Return on assets | -29.19% | — |
Return on capital | -81.56% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -15.03M | -34.81% |
Cash from operations | -9.60M | -14.94% |
Cash from investing | 10.90M | 22.26% |
Cash from financing | 87.00K | -54.21% |
Net change in cash | 1.56M | 46.94% |
Free cash flow | -4.72M | -13.90% |
About
Founded
2012
Headquarters
Website
Employees
36
